1. Home
  2. HNI vs NVCR Comparison

HNI vs NVCR Comparison

Compare HNI & NVCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo HNI Corporation

HNI

HNI Corporation

HOLD

Current Price

$34.85

Market Cap

2.4B

ML Signal

HOLD

Logo NovoCure Limited

NVCR

NovoCure Limited

HOLD

Current Price

$14.20

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HNI
NVCR
Founded
1944
2000
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Office Equipment/Supplies/Services
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.4B
2.0B
IPO Year
1994
2015

Fundamental Metrics

Financial Performance
Metric
HNI
NVCR
Price
$34.85
$14.20
Analyst Decision
Strong Buy
Buy
Analyst Count
1
6
Target Price
$70.00
$28.08
AVG Volume (30 Days)
662.7K
1.6M
Earning Date
05-06-2026
04-30-2026
Dividend Yield
3.73%
N/A
EPS Growth
N/A
21.79
EPS
N/A
N/A
Revenue
$2,839,000,000.00
$655,353,000.00
Revenue This Year
$117.19
$7.72
Revenue Next Year
$3.68
$6.74
P/E Ratio
N/A
N/A
Revenue Growth
12.37
8.28
52 Week Low
$28.93
$9.82
52 Week High
$53.29
$18.92

Technical Indicators

Market Signals
Indicator
HNI
NVCR
Relative Strength Index (RSI) 62.46 36.95
Support Level $33.72 $12.66
Resistance Level $47.41 $15.46
Average True Range (ATR) 1.45 1.04
MACD 0.47 -0.27
Stochastic Oscillator 93.01 8.87

Price Performance

Historical Comparison
HNI
NVCR

About HNI HNI Corporation

HNI Corp is a provider of commercial furnishings and hearth products. Its two reportable segments are workplace furnishings and residential building products. The workplace furnishings segment includes furniture systems, seating, storage, tables, architectural products, ancillary products, and hospitality products. The residential building products segment includes various gas, wood, electric, and pellet-fueled fireplaces, inserts, stoves, facings, outdoor fire pits and fire tables, and accessories. The company's products are sold through independent dealers, distributors, eCommerce retailers, wholesalers, and retail outlets. A majority of the firm's revenue is generated from the Workplace furnishings segment. Geographically, it operates in the United States.

About NVCR NovoCure Limited

NovoCure Ltd is an oncology company with a proprietary platform technology in the United States. Its business involves the development, manufacture, and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis, and other products and technologies for the treatment of Glioblastoma, Non-small cell lung cancer, and Pancreatic cancer. Geographically, the company derives the majority of its revenue from the United States and the rest from Germany, Japan, and other markets.

Share on Social Networks: